Mutual of America Capital Management LLC Sells 407 Shares of Plexus Corp. (NASDAQ:PLXS)

Mutual of America Capital Management LLC cut its stake in Plexus Corp. (NASDAQ:PLXSFree Report) by 9.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,095 shares of the technology company’s stock after selling 407 shares during the period. Mutual of America Capital Management LLC’s holdings in Plexus were worth $560,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of PLXS. American Century Companies Inc. raised its position in Plexus by 204.3% in the 2nd quarter. American Century Companies Inc. now owns 158,032 shares of the technology company’s stock worth $16,306,000 after purchasing an additional 106,103 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in shares of Plexus by 8.8% during the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,079,340 shares of the technology company’s stock valued at $111,366,000 after acquiring an additional 87,574 shares during the period. Assenagon Asset Management S.A. boosted its holdings in Plexus by 158.0% in the third quarter. Assenagon Asset Management S.A. now owns 82,575 shares of the technology company’s stock valued at $11,289,000 after acquiring an additional 50,564 shares during the last quarter. Speece Thorson Capital Group Inc. increased its position in Plexus by 197.1% in the second quarter. Speece Thorson Capital Group Inc. now owns 50,498 shares of the technology company’s stock worth $5,210,000 after purchasing an additional 33,501 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Plexus by 7.4% in the second quarter. Bank of New York Mellon Corp now owns 453,308 shares of the technology company’s stock worth $46,772,000 after purchasing an additional 31,099 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Plexus Stock Up 2.0 %

Shares of NASDAQ PLXS opened at $164.54 on Wednesday. The firm has a 50 day moving average price of $143.70 and a 200 day moving average price of $124.68. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.71 and a current ratio of 1.51. The stock has a market cap of $4.46 billion, a P/E ratio of 41.05 and a beta of 0.87. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $169.41.

Plexus (NASDAQ:PLXSGet Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.30. The business had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.44 EPS. Analysts expect that Plexus Corp. will post 6.14 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. Benchmark raised their price objective on shares of Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, October 28th. KeyCorp assumed coverage on shares of Plexus in a report on Tuesday, October 22nd. They set a “sector weight” rating for the company. Finally, Needham & Company LLC raised their price target on Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $133.50.

Get Our Latest Stock Report on Plexus

Insiders Place Their Bets

In related news, Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $128.02, for a total value of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares of the company’s stock, valued at approximately $1,227,199.72. This represents a 4.96 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Angelo Michael Ninivaggi, Jr. sold 3,113 shares of Plexus stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $144.19, for a total value of $448,863.47. Following the completion of the sale, the chief accounting officer now directly owns 35,323 shares in the company, valued at $5,093,223.37. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,091 shares of company stock worth $5,207,385 over the last ninety days. 2.39% of the stock is currently owned by corporate insiders.

Plexus Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.